PubMed COVID-19 Clinical Care

CONCLUSION: This retrospective study provides insights into the clinical characteristics and outcomes of COVID-19 patients. Age, male gender, comorbidities, and specific symptoms were associated with disease severity. Inflammatory markers, including

No abstract

Restrictions associated with the onset of the COVID-19 pandemic created a host of short- and long-term economic challenges for families. Despite their ubiquity during the early pandemic, knowledge on the developmental impacts of pandemic-related

CONCLUSIONS: The importance of in-person interactions, local coalitions, and community contexts may play a key role for successfully increasing colorectal cancer screening rates among African Americans as reflected through this study. The integration

Community outreach and engagement (COE) is a fundamental activity of cancer centers as they aim to reduce cancer disparities in their geographic catchment areas. As part of COE, National Cancer Institute (NCI)-designated cancer centers must monitor

CONCLUSION: A large number of practices are making a key contribution to combating the pandemic by participating in the COVID-19 vaccination campaign, but this is also associated with a high workload situation. This is exacerbated by the dynamics of

BACKGROUND: Alcohol consumption is widespread with over half of the individuals over 18 years of age in the U.S. reporting alcohol use in the last 30 days. Moreover, 9 million Americans engaged in binge or chronic heavy drinking (CHD) in 2019. CHD

CONCLUSION: The results of this study showed that there is a higher risk of reinfection in several vulnerable groups including healthcare providers, young individuals, residents of urban areas, men, and individuals with underlying diseases.

The COVID-19 pandemic has altered the lives of millions of individuals, resulting in over 600 million cases and over 6 million fatalities worldwide. In developing nations, mortality rates for intubated patients with viral pneumonia were as high as 80

CONCLUSION: Completing a COVID-19 trial in outpatients during the height of the pandemic required multiple innovations in nearly every aspect of clinical trial management, a high commitment level from study staff and patients, and support from study